The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine

被引:45
|
作者
Davis, MP [1 ]
Homsi, J [1 ]
机构
[1] Cleveland Clin Fdn, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44195 USA
关键词
CYP2D6; palliative medicine; drug metabolism; drug interactions; ethnic differences; pharmacokinetics;
D O I
10.1007/s005200000222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.
引用
收藏
页码:442 / 451
页数:10
相关论文
共 50 条
  • [21] Cytochrome P450-2D6 (CYP2D6) genotypes in normal controls
    de Leon, J
    Rogers, T
    Brumagen, J
    Weddle, L
    Wedlund, PJ
    Chou, WH
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 47S - 47S
  • [22] Epitope Mapping of Cytochrome P450 2D6 in Patients with Autoimmune Hepatitis and in the CYP2D6 Mouse Model
    Hintermann, Edith
    Holdener, Martin
    Bayer, Monika
    Manns, Michael
    Christen, Urs
    CLINICAL IMMUNOLOGY, 2009, 131 : S135 - S136
  • [23] Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
    Bezerra, Lucas Soares
    Oliveira Santos-Veloso, Marcelo Antonio
    Bezerra Junior, Natanael da Silva
    da Fonseca, Lucilia Carvalho
    Andrade Sales, Wivianne Lisley
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2018, 40 (12): : 794 - 799
  • [24] Variability in the frequency of cytochrome P450-2D6 (CYP2D6) deficiency
    Mörike, K
    Platten, HP
    Mikus, G
    Klotz, U
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (01) : 87 - 87
  • [25] Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity Role of CYP2D6 and CYP2C19 in longevityRole of CYP2D6 and CYP2C19 in longevity
    L. Bathum
    K. Andersen-Ranberg
    J. Boldsen
    K. Brøsen
    B. Jeune
    European Journal of Clinical Pharmacology, 1998, 54 : 427 - 430
  • [26] Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice
    Felmlee, Melanie A.
    Lon, Hoi-Kei
    Gonzalez, Frank J.
    Yu, Ai-Ming
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 435 - 441
  • [27] Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis
    Beyeler, C
    Armstrong, M
    Bird, HA
    Idle, JR
    Daly, AK
    ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (01) : 66 - 68
  • [28] Influence of a mutation reducing the catalytic activity of the cytochrome P450 CYP2D6 on lung cancer susceptibility
    Legrand, M
    Stucker, I
    Marez, D
    Sabbagh, N
    LoGuidice, JM
    Broly, F
    CARCINOGENESIS, 1996, 17 (10) : 2267 - 2269
  • [29] Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems
    Paine, MJI
    Gilham, D
    Roberts, GCK
    Wolf, CR
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 328 (01) : 143 - 150
  • [30] The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients
    Topic, E
    Stefanovic, M
    Ivanisevic, AM
    Petrinovic, R
    Curcic, I
    CLINICA CHIMICA ACTA, 2000, 296 (1-2) : 101 - 109